There’s no question we’re missing something,” said Dr. Marwan Fakih, a gastrointestinal oncologist at City of Hope in Duarte, Calif., while lamenting about a cancer mystery that is confounding doctors ...
ORNL's AI reduces cancer report processing time from 22 to 14 months, aiding faster cancer trend identification.
Enhertu first secured approval in 2019 for patients with high levels of HER2, a protein that promotes cancer cell growth. In ...
Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...
According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...
A new report from the National Cancer Institute shows a major disparity in the rates of stomach cancer in people of different ...
A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.
New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in early-stage colorectal cancer.
A new study finds forever chemicals or PFAS in US tap water increases cancer risk by up to 33%. Researchers link them to ...
Trump is giving Democrats so many targets. If only they would take them. In his first week in office, President Donald Trump ...
Outer Banks Health welcomes Michael Spiritos, medical oncologist, to its team of healthcare professionals at the Cowell ...
Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.